NASDAQ:LFCR Lifecore Biomedical Q1 2026 Earnings Report $6.54 +0.02 (+0.23%) As of 11:47 AM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Lifecore Biomedical EPS ResultsActual EPS-$0.29Consensus EPS -$0.30Beat/MissBeat by +$0.01One Year Ago EPSN/ALifecore Biomedical Revenue ResultsActual Revenue$31.11 millionExpected Revenue$26.68 millionBeat/MissBeat by +$4.43 millionYoY Revenue GrowthN/ALifecore Biomedical Announcement DetailsQuarterQ1 2026Date11/6/2025TimeAfter Market ClosesConference Call DateThursday, November 6, 2025Conference Call Time7:00AM ETUpcoming EarningsLifecore Biomedical's Q3 2026 earnings is estimated for Friday, October 2, 2026, based on past reporting schedulesConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) Lifecore Biomedical Earnings HeadlinesLifecore Biomedical (NASDAQ:LFCR) Stock Rating Lowered by Barrington ResearchOctober 1 at 1:24 AM | americanbankingnews.comHalper Sadeh LLC is Investigating Whether LFCR and SSTI are Obtaining Fair Deals for their ShareholdersSeptember 30 at 9:17 PM | globenewswire.comThe SEC Just Opened The Floodgates…The SEC removed the 25 year old Pattern Day Trader rule in June 2026, cutting the minimum to open a trading account to just 2,000 dollars. Small cap stocks like ONFO, CURR, RMSG, TMDE and VSME have already posted gains ranging from 140 percent to 482 percent, some in a single day. Tim Bohen, known for flagging Tesla at 37 and Nvidia at 6.93, believes this shift could trigger the next major small cap breakout.October 2 at 1:00 AM | StocksToTrade (Ad)Lifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCRSeptember 30 at 7:05 PM | businesswire.comBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capital Bancorp, Inc. (Nasdaq – CBNK), Lifecore Biomedical, Inc. (Nasdaq – LFCR), MISTRAS Group, Inc. (NYSE – MG), Utz Brands, Inc. (NYSE – UTZ)September 30 at 2:04 PM | globenewswire.comLifecore agrees to acquisition with CVRs up to $160 millionSeptember 30 at 2:03 AM | americanbankingnews.comSee More Lifecore Biomedical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Lifecore Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your email. Email Address About Lifecore BiomedicalLifecore Biomedical (NASDAQ:LFCR) is a contract development and manufacturing organization (CDMO) that provides services to pharmaceutical, biotechnology and medical device companies. The company specializes in complex sterile injectable products and supports customers through product development, process development, manufacturing, aseptic filling, packaging and related regulatory services. Lifecore’s capabilities include the production of injectable products using fermentation and other specialized manufacturing processes. The company is also known for its expertise in hyaluronic acid, which is used in pharmaceutical, ophthalmic and medical device applications. Its services are designed to support products from early development through commercial-scale production. The company operates a manufacturing facility in Chaska, Minnesota, and serves customers in the United States and international markets. Lifecore Biomedical was formerly part of Landec Corporation. Following the divestiture of Landec’s food business, Landec changed its name to Lifecore Biomedical in 2023 to reflect its focus on pharmaceutical and life sciences manufacturing.View Lifecore Biomedical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Micron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes NextTarget's Holiday Blitz: Slashing Prices to Capture Market ShareCleared for Takeoff: AAR Corp. Expands Its Aerospace Aftermarket ReachJabil’s Double-Beat and Raise Is a Signal That This Rally Will Continue Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
